Musgrove EA - Search Results

1

Mutated in colorectal cancer protein modulates the NFκB pathway.

Sigglekow ND, Pangon L, Brummer T, Molloy M, Hawkins NJ, Ward RL, Musgrove EA, Kohonen-Corish MR. Sigglekow ND, et al. Among authors: musgrove ea. Anticancer Res. 2012 Jan;32(1):73-9. Anticancer Res. 2012. PMID: 22213290

2

The "Mutated in Colorectal Cancer" Protein Is a Novel Target of the UV-Induced DNA Damage Checkpoint.

Pangon L, Sigglekow ND, Larance M, Al-Sohaily S, Mladenova DN, Selinger CI, Musgrove EA, Kohonen-Corish MR. Pangon L, et al. Among authors: musgrove ea. Genes Cancer. 2010 Sep;1(9):917-26. doi: 10.1177/1947601910388937. Genes Cancer. 2010. PMID: 21779472 Free PMC article.

3

The PDZ-binding motif of MCC is phosphorylated at position -1 and controls lamellipodia formation in colon epithelial cells.

Pangon L, Van Kralingen C, Abas M, Daly RJ, Musgrove EA, Kohonen-Corish MR. Pangon L, et al. Among authors: musgrove ea. Biochim Biophys Acta. 2012 Jun;1823(6):1058-67. doi: 10.1016/j.bbamcr.2012.03.011. Epub 2012 Mar 28. Biochim Biophys Acta. 2012. PMID: 22480440 Free article.

4

Sulindac activates NF-κB signaling in colon cancer cells.

Mladenova D, Pangon L, Currey N, Ng I, Musgrove EA, Grey ST, Kohonen-Corish MR. Mladenova D, et al. Among authors: musgrove ea. Cell Commun Signal. 2013 Oct 1;11:73. doi: 10.1186/1478-811X-11-73. Cell Commun Signal. 2013. PMID: 24083678 Free PMC article.

5

The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.

Mladenova D, Daniel JJ, Dahlstrom JE, Bean E, Gupta R, Pickford R, Currey N, Musgrove EA, Kohonen-Corish MR. Mladenova D, et al. Among authors: musgrove ea. Gut. 2011 Mar;60(3):350-60. doi: 10.1136/gut.2010.208314. Epub 2010 Oct 27. Gut. 2011. PMID: 20980345

6

Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking protein.

Brummer T, Schramek D, Hayes VM, Bennett HL, Caldon CE, Musgrove EA, Daly RJ. Brummer T, et al. Among authors: musgrove ea. J Biol Chem. 2006 Jan 6;281(1):626-37. doi: 10.1074/jbc.M509567200. Epub 2005 Oct 27. J Biol Chem. 2006. PMID: 16253990 Free article.

7

p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells.

Carroll JS, Lynch DK, Swarbrick A, Renoir JM, Sarcevic B, Daly RJ, Musgrove EA, Sutherland RL. Carroll JS, et al. Among authors: musgrove ea. Cancer Res. 2003 Aug 1;63(15):4322-6. Cancer Res. 2003. PMID: 12907598

8

Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib.

Timpson P, Wilson AS, Lehrbach GM, Sutherland RL, Musgrove EA, Daly RJ. Timpson P, et al. Among authors: musgrove ea. Cancer Res. 2007 Oct 1;67(19):9304-14. doi: 10.1158/0008-5472.CAN-07-0798. Cancer Res. 2007. PMID: 17909038

9

Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.

Carroll JS, Swarbrick A, Musgrove EA, Sutherland RL. Carroll JS, et al. Among authors: musgrove ea. Cancer Res. 2002 Jun 1;62(11):3126-31. Cancer Res. 2002. PMID: 12036924

10

Cell cycle control in breast cancer cells.

Caldon CE, Daly RJ, Sutherland RL, Musgrove EA. Caldon CE, et al. Among authors: musgrove ea. J Cell Biochem. 2006 Feb 1;97(2):261-74. doi: 10.1002/jcb.20690. J Cell Biochem. 2006. PMID: 16267837 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters